Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.33 USD | -2.92% | -2.10% | +0.43% |
05-09 | Transcript : Mersana Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
05-09 | Earnings Flash (MRSN) MERSANA THERAPEUTICS Posts Q1 Revenue $9.2M, vs. Street Est of $8.5M | MT |
Sales 2024 * | 35.91M 48.88M | Sales 2025 * | 33.12M 45.09M | Capitalization | 285M 388M |
---|---|---|---|---|---|
Net income 2024 * | -84M -114M | Net income 2025 * | -99M -135M | EV / Sales 2024 * | 5.38 x |
Net cash position 2024 * | 91.88M 125M | Net cash position 2025 * | 44.36M 60.39M | EV / Sales 2025 * | 7.27 x |
P/E ratio 2024 * |
-3.47
x | P/E ratio 2025 * |
-3.19
x | Employees | 123 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.3% |
Latest transcript on Mersana Therapeutics, Inc.
1 day | -2.92% | ||
1 week | -2.10% | ||
1 month | -30.65% | ||
3 months | -60.77% | ||
6 months | +22.63% | ||
Current year | +0.43% |
Managers | Title | Age | Since |
---|---|---|---|
Martin Huber
CEO | Chief Executive Officer | 64 | 20-04-12 |
Director of Finance/CFO | 46 | 19-07-09 | |
David Mott
CHM | Chairman | 58 | 12-07-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kristen Hege
BRD | Director/Board Member | 60 | 16-07-31 |
David Mott
CHM | Chairman | 58 | 12-07-30 |
Anna Protopapas
BRD | Director/Board Member | 59 | 15-03-01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.05% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - | |
0.03% | 234 M€ | +8.48% | - | |
0.02% | 1,487 M€ | +7.77% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 2.33 | -2.92% | 669,923 |
24-05-30 | 2.4 | +2.13% | 807,111 |
24-05-29 | 2.35 | -2.08% | 1,342,732 |
24-05-28 | 2.4 | +0.84% | 1,454,677 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.43% | 285M | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |
- Stock Market
- Equities
- MRSN Stock